John D. Quisel, EVP, Chief Business Officer at ACCELERON PHARMA INC (XLRN), sold 10,084 shares at $52.51 ($530K) on 2020-01-02, disclosed to the SEC on 2020-01-03.
Seasonal sale ($530k) by EVP, Chief Business Officer — this insider has traded XLRN in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.51 | 1,600 | $84K | 15.9% |
| 2 | $52.52 | 4,242 | $223K | 42.1% |
| 3 | $52.52 | 4,242 | $223K | 42.1% |
| Total | $52.52 avg | 10,084 | $530K | 100% |
| Filing → |
| IRON | SELL | 2026-06-23 | $2.4M | — | Filing → |
| IRON | SELL | 2026-02-17 | $834K | — | Filing → |
| IRON | SELL | 2025-12-15 | $7.4M | — | Filing → |